Historical Valuation
Bon Natural Life Ltd (BON) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.11 is considered Undervalued compared with the five-year average of 4.95. The fair price of Bon Natural Life Ltd (BON) is between 13.12 to 14.29 according to relative valuation methord. Compared to the current price of 1.69 USD , Bon Natural Life Ltd is Undervalued By 87.12%.
Relative Value
Fair Zone
13.12-14.29
Current Price：1.69
87.12%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Bon Natural Life Ltd (BON) has a current Price-to-Book (P/B) ratio of 0.01. Compared to its 3-year average P/B ratio of 0.14 , the current P/B ratio is approximately -94.67% higher. Relative to its 5-year average P/B ratio of 0.59, the current P/B ratio is about -98.76% higher. Bon Natural Life Ltd (BON) has a Forward Free Cash Flow (FCF) yield of approximately -157.83%. Compared to its 3-year average FCF yield of -303.52%, the current FCF yield is approximately -48.00% lower. Relative to its 5-year average FCF yield of -204.74% , the current FCF yield is about -22.91% lower.
P/B
Median3y
0.14
Median5y
0.59
FCF Yield
Median3y
-303.52
Median5y
-204.74
Competitors Valuation Multiple
AI Analysis for BON
The average P/S ratio for BON competitors is 3.62, providing a benchmark for relative valuation. Bon Natural Life Ltd Corp (BON.O) exhibits a P/S ratio of 0.11, which is -96.95% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
AI Analysis for BON
1Y
3Y
5Y
Market capitalization of BON increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of BON in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is BON currently overvalued or undervalued?
Bon Natural Life Ltd (BON) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.11 is considered Undervalued compared with the five-year average of 4.95. The fair price of Bon Natural Life Ltd (BON) is between 13.12 to 14.29 according to relative valuation methord. Compared to the current price of 1.69 USD , Bon Natural Life Ltd is Undervalued By 87.12% .
What is Bon Natural Life Ltd (BON) fair value?
BON's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Bon Natural Life Ltd (BON) is between 13.12 to 14.29 according to relative valuation methord.
How does BON's valuation metrics compare to the industry average?
The average P/S ratio for BON's competitors is 3.62, providing a benchmark for relative valuation. Bon Natural Life Ltd Corp (BON) exhibits a P/S ratio of 0.11, which is -96.95% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for Bon Natural Life Ltd (BON) as of Jan 10 2026?
As of Jan 10 2026, Bon Natural Life Ltd (BON) has a P/B ratio of 0.01. This indicates that the market values BON at 0.01 times its book value.
What is the current FCF Yield for Bon Natural Life Ltd (BON) as of Jan 10 2026?
As of Jan 10 2026, Bon Natural Life Ltd (BON) has a FCF Yield of -157.83%. This means that for every dollar of Bon Natural Life Ltd’s market capitalization, the company generates -157.83 cents in free cash flow.
What is the current Forward P/E ratio for Bon Natural Life Ltd (BON) as of Jan 10 2026?
As of Jan 10 2026, Bon Natural Life Ltd (BON) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of Bon Natural Life Ltd’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Bon Natural Life Ltd (BON) as of Jan 10 2026?
As of Jan 10 2026, Bon Natural Life Ltd (BON) has a Forward P/S ratio of 0.11. This means the market is valuing BON at $0.11 for every dollar of expected revenue over the next 12 months.